CYBN
Price:
$0.2102
Market Cap:
$216.68M
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.[Read more]
Industry
Biotechnology
IPO Date
2019-09-13
Stock Exchange
AMEX
Ticker
CYBN
According to Cybin Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 41.70. This represents a change of 131.67% compared to the average of 18.00 of the last 4 quarters.
The mean historical Current Ratio of Cybin Inc. over the last ten years is 13.58. The current 41.70 Current Ratio has changed 30.60% with respect to the historical average. Over the past ten years (40 quarters), CYBN's Current Ratio was at its highest in in the June 2024 quarter at 41.70. The Current Ratio was at its lowest in in the December 2019 quarter at 0.
Average
13.58
Median
10.47
Minimum
2.88
Maximum
27.38
Discovering the peaks and valleys of Cybin Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 850.16%
Maximum Annual Current Ratio = 27.38
Minimum Annual Increase = -73.26%
Minimum Annual Current Ratio = 2.88
Year | Current Ratio | Change |
---|---|---|
2024 | 21.65 | 193.33% |
2023 | 7.38 | -45.61% |
2022 | 13.57 | 117.59% |
2021 | 6.24 | 0% |
2020 | 6.24 | -73.26% |
2019 | 23.32 | -14.83% |
2018 | 27.38 | 850.16% |
The current Current Ratio of Cybin Inc. (CYBN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.20
5-year avg
11.01
10-year avg
13.58
Cybin Inc.’s Current Ratio is greater than Mind Medicine (MindMed) Inc. (5.92), greater than Seelos Therapeutics, Inc. (0.08), greater than GH Research PLC (19.60), greater than Awakn Life Sciences Corp. (0.09), greater than Atai Life Sciences N.V. (6.68), greater than Fortress Biotech, Inc. (1.37), greater than Bio-Path Holdings, Inc. (1.67), greater than Vaccinex, Inc. (0.42), less than Eliem Therapeutics, Inc. (60.41), greater than Opthea Limited (2.94), greater than Molecular Partners AG (14.58), greater than Edgewise Therapeutics, Inc. (30.24), greater than iTeos Therapeutics, Inc. (18.08), greater than Immix Biopharma, Inc. (7.00), greater than CNS Pharmaceuticals, Inc. (0.31), greater than VectivBio Holding AG (9.14), greater than Zura Bio Limited (12.57), greater than ZyVersa Therapeutics, Inc. (0.06),
Company | Current Ratio | Market cap |
---|---|---|
5.92 | $483.69M | |
0.08 | $1.59M | |
19.60 | $428.19M | |
0.09 | $4.43M | |
6.68 | $199.68M | |
1.37 | $40.38M | |
1.67 | $2.51M | |
0.42 | $9.73M | |
60.41 | $495.57M | |
2.94 | $444.73M | |
14.58 | $182.90M | |
30.24 | $1.64B | |
18.08 | $540.52M | |
7.00 | $54.08M | |
0.31 | $4.60M | |
9.14 | $1.06B | |
12.57 | $230.86M | |
0.06 | $2.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cybin Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cybin Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cybin Inc.'s Current Ratio?
How is the Current Ratio calculated for Cybin Inc. (CYBN)?
What is the highest Current Ratio for Cybin Inc. (CYBN)?
What is the 3-year average Current Ratio for Cybin Inc. (CYBN)?
What is the 5-year average Current Ratio for Cybin Inc. (CYBN)?
How does the current Current Ratio for Cybin Inc. (CYBN) compare to its historical average?